Tyrosine-protein kinase Lck
Details
- Name
- Tyrosine-protein kinase Lck
- Kind
- protein
- Organism
- Humans
- Protein
Name UniProt ID Tyrosine-protein kinase Lck P06239 Details
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB01254 Dasatinib approved, investigational yes inhibitormultitarget Details DB01830 AP-22408 experimental unknown Details DB02010 Staurosporine experimental unknown Details DB03023 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine experimental unknown Details DB04003 {4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid experimental unknown Details DB04395 Phosphoaminophosphonic Acid-Adenylate Ester experimental unknown Details DB06925 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE experimental unknown Details DB07146 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE experimental unknown Details DB07297 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE experimental unknown Details DB08055 N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine experimental unknown Details DB08056 N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine experimental unknown Details DB08057 N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine experimental unknown Details DB08901 Ponatinib approved, investigational unknown inhibitor Details DB09079 Nintedanib approved unknown inhibitor Details DB12010 Fostamatinib approved, investigational unknown inhibitor Details DB15035 Zanubrutinib approved, investigational unknown inhibitor Details DB16656 Zotiraciclib investigational unknown inhibitor Details